Join us for our next #thoracic Global Grand Rounds webinar Wednesday at 8am ET where speakers will highlight key findings from our International #Thoracic Surgical #Oncology Summit (#ITSOS2023) last month: aats.org/events/best-of…

Outstanding presention of #CM77T by Dr. Tina Cascone at #ESMO23 ! EFS HR 0.58 strongly favors periop chemo-IO across PD-L1 strata, high pCR rate 25% (51%! in PDL1 high) and overall better surgical outcomes in chemo-IO arm. So #CM816 vs #CM77T vs #KN671? #LCSM

The strength and impact of the STS Compensation survey will depend on the number of respondents. The results are shared with Gallagher- and STS does not have access except anonymized aggregate data. Our transplant surgeons have a 97% response rate to a similar approach.

Save the date for #ITSOS204! We'll be at the Sheraton New York Times Square September 27-28 for next year's international thoracic surgical oncology summit. #ITSOS2023 was the largest Summit to date so you don't want to miss it! events.aats.org/itsos24

🎗️November is Lung Cancer Awareness Month. 🫁 Sadly, it's the leading cause of cancer-related death in the US. Let's join forces to raise awareness, increase screening rates, and improve survival. Together, we can make an impact! Johns Hopkins Medicine

What a treat! “Biology beats technique every time”.

Here's our latest from Johns Hopkins Thoracic Oncology & Molecular OncologyLab, hot-off-the-press in Nature Medicine. What do we learn from neoadjuvant anti-PD1 & anti-LAG3 through the lens of liquid biopsies? Enjoy the read! nature.com/articles/s4159… Vincent Lam Cancer Research Institute Blair Landon

Phase III, surgical outcomes, ALINA trial. #NSCLC #AATS2024

Super proud! Way to go KPB!!

I think Blue Angels made the lung cancer ribbon over Annapolis (again)!@HopkinsThoracic Johns Hopkins Cardiothoracic Surgery

Less than 3 weeks left to submit your work to #ITSOS2024. The June 24 deadline will be here before you know it - present your #thoracic oncology research with us and receive an accelerated review by the #JTCVS Editorial Board. Submit: events.aats.org/itsos24/call-f…

New PRS Global Open paper (bit.ly/4cQpeJW) by Johns Hopkins Plastic & Reconstructive Surgery & Hopkins Surgery reviews 9 FDA-approved #BreastCancer #immunotherapies. Recommends individualized work-up to avoid complications during reconstruction. #PlasticSurgery #BreastReconstruction Johns Hopkins Medicine

Congrats to Dr. Kristen Broderick named one of America’s Best Plastic Surgeons for #breastaugmentation by @newsweek. Dr. Broderick specializes in #breastreconstruction after cancer, body contouring & cosmetic #plasticsurgery.

Registration is open for #ITSOS2024 in New York! Innovative #thoracic oncology presentations, new connections, and insightful discussions Register by the early bird deadline on 8/26: events.aats.org/itsos24/regist…

🫁 Join us for part 1 of a three-part series—learn more about ICI–based neoadjuvant or perioperative regimens for treatment of early-stage resectable #NSCLC. Register now for the Aug 23 event. bit.ly/46XyZnO w/Patrick Forde Stephen R Broderick MD MPHS #LungCancer #AnswersInCMELive

Rosemary is AMAZING! Such a valuable asset for our patients. Sibley Hospital JHM

Surprising results, stereotactic radiation plus anti-PD1 for stage 1-2 NSCLC, addition of immunotherapy does not confer benefit #lcsm merck.com/news/merck-pro…

NESPS program co-chairs Johns Hopkins Plastic & Reconstructive Surgery Dr. Kristen Broderick , Dr. Ashley Amalfi and President Stony Brook Medicine Dr. Tara Huston ran a great meeting! Congratulations. #plasticsurgery